LFCR

LIFECORE BIOMEDICAL INC

LFCR·514766104·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

LFCR (LIFECORE BIOMEDICAL INC) is held by 57 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($7M), VANGUARD CAPITAL MANAGEMENT LLC ($4.8M), GEODE CAPITAL MANAGEMENT, LLC ($3M). Net institutional sentiment: Mixed.

57
Holders
Avg rating(13 Elite)
$28.1M
Total Value
53% (64)
Fund Consensus
30 buying - 27 selling
LFCRSmart Money Verdict
View all
Held by 57 funds
13 elite
Who's Trading
ActivistLILegion Partners, L.P. I15.6%Jul 2, 2026
Activist2222NW Fund, LP6.7%Jul 2, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.0%Apr 27, 2026
Activist2222NW Fund, LP7.5%May 29, 2025
InsiderEREnglish Aron R.Sell $1.1MMay 28, 2025
InsiderEREnglish Aron R.Sell $7.4MMay 27, 2025
InsiderEREnglish Aron R.Sell $649KMay 23, 2025
InsiderEREnglish Aron R.Sell $86KMay 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.9M(-1.6%)$7M0.0%-36.19%
0
New
1.3M$4.8M0.0%-32.05%
37
Increased
815,107(+4.5%)$3M0.0%-37.69%
28
Increased
764,734(+1.8%)$2.8M0.0%-11.40%
27
Increased
642,006(+9.7%)$2.4M0.0%-27.62%
29
New
237,065$881,8820.0%-32.05%
34
Increased
228,158(+1.4%)$848,7480.0%-33.77%
25
Increased
207,790(+84.2%)$772,9790.0%-31.41%
38
Increased
168,376(+79.8%)$626,3590.0%-35.27%
37
New
164,560$612,1630.0%-32.05%
37
Decreased
157,157(-37.6%)$584,6240.0%-36.70%
0
Unchanged
83,800$311,7360.0%-51.05%
0
Decreased
79,978(-8.8%)$297,5180.0%-28.12%
0
New
75,097$279,3610.0%-32.05%
32
Increased
69,992(+27.8%)$260,3700.0%-33.84%
20
Decreased
58,466(-0.7%)$217,4930.0%-22.61%
0
Decreased
58,354(-47.3%)$217,0780.0%-32.36%
0
Decreased
52,404(-52.6%)$194,9430.0%-31.96%
0
Increased
43,298(+64.4%)$161,0680.0%-35.74%
22
Decreased
40,789(-59.2%)$151,7350.0%-40.45%
0

Showing 1-20 of 64

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used